NS5A: A new target for antiviral drugs in the treatment of hepatitis C virus infection

被引:6
|
作者
Debes, Jose D. [1 ]
Smith, Coleman I. [1 ]
机构
[1] Univ Minnesota, Plymouth, MN USA
关键词
GENOTYPE; 1; PROTEIN; REPLICATION; INHIBITOR; BMS-790052;
D O I
10.1002/hep.25696
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:797 / 799
页数:3
相关论文
共 50 条
  • [31] Hepatitis C virus NS5A protein-A master regulator?
    Szabo, GY
    GASTROENTEROLOGY, 2006, 130 (03) : 995 - 999
  • [32] Functional Role of Hepatitis C Virus NS5A in the Regulation of Autophagy
    Ke, Po-Yuan
    Yeh, Chau-Ting
    PATHOGENS, 2024, 13 (11):
  • [33] Correlation between NS5A Dimerization and Hepatitis C Virus Replication
    Lim, Precious J.
    Chatterji, Udayan
    Cordek, Daniel
    Sharma, Suresh D.
    Garcia-Rivera, Jose A.
    Cameron, Craig E.
    Lin, Kai
    Targett-Adams, Paul
    Gallay, Philippe A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (36) : 30861 - 30873
  • [34] Daclatasvir: A NS5A Replication Complex Inhibitor for Hepatitis C Infection
    Smith, Michael A.
    Regal, Randolph E.
    Mohammad, Rima A.
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (01) : 39 - 46
  • [35] Identification of a novel phosphorylation site in hepatitis C virus NS5A
    Gilliver, Anna Nordle
    Griffin, Stephen
    Harris, Mark
    JOURNAL OF GENERAL VIROLOGY, 2010, 91 : 2428 - 2432
  • [36] Hepatitis C virus NS5A inhibitors and drug resistance mutations
    Shingo Nakamoto
    Tatsuo Kanda
    Shuang Wu
    Hiroshi Shirasawa
    Osamu Yokosuka
    World Journal of Gastroenterology, 2014, (11) : 2902 - 2912
  • [37] Odalasvir Nonstructural protein 5A (NS5A) inhibitor Treatment of hepatitis C virus (HCV)
    Kanda, T.
    Moriyama, M.
    DRUGS OF THE FUTURE, 2017, 42 (09) : 549 - 553
  • [38] Prevalence of NS5A resistance associated variants in NS5A inhibitor treatment failures and an effective treatment for NS5A-P32 deleted hepatitis C virus in humanized mice
    Teraoka, Yuji
    Uchida, Takuro
    Imamura, Michio
    Osawa, Mitsutaka
    Tsuge, Masataka
    Abe-Chayama, Hiromi
    Hayes, C. Nelson
    Makokha, Grace Naswa
    Aikata, Hiroshi
    Miki, Daiki
    Ochi, Hidenori
    Ishida, Yuji
    Tateno, Chise
    Chayama, Kazuaki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 500 (02) : 152 - 157
  • [39] Prevalence of NS5A Resistance Associated Variants in NS5A Inhibitor Treatment Failures and an Effective Treatment for NS5A-P32 Deleted Hepatitis C Virus in Humanized Mice
    Teraoka, Yuji
    Uchida, Takuro
    Imamura, Michio
    Osawa, Mitutaka
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Abe-Chayama, Hiromi
    Hayes, Nelson
    Makokha, Grace Naswa
    Aikata, Hiroshi
    Miki, Daiki
    Ochi, Hidenori
    Ishida, Yuji
    Tateno, Chise
    Chayama, Kazuaki
    HEPATOLOGY, 2018, 68 : 384A - 384A
  • [40] HEPATITIS C VIRUS: Effect Of NS5A On The NS5B in vitro Replication Reaction
    Quezada, Elizabeth M.
    Kane, Caroline M.
    FASEB JOURNAL, 2008, 22